Polaryx Therapeutics PLYX
NASDAQ PLYX
$1.93 -0.01 (-0.52%)
As of: Oct 22, 2026 · 2:42 PM EDT

Polaryx Therapeutics (PLYX) Common Stock Issued (2025)

Updated

Analysis

Polaryx Therapeutics (PLYX) Common Stock Issued (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Issued (Qtr)
1 Eli Lilly 1,166.05 Bn 1,134.64 Bn 19.71 Bn -
2 Johnson & Johnson 647.70 Bn 567.56 Bn 17.30 Bn 743.00 Mn
3 AbbVie 503.26 Bn 476.37 Bn 12.70 Bn -
4 Merck 366.29 Bn 320.67 Bn 12.21 Bn 43.00 Mn
5 Novartis Ag 303.09 Bn 267.08 Bn 11.24 Bn -
6 Astrazeneca 268.96 Bn 242.64 Bn 12.86 Bn 6.00 Mn
7 Amgen 242.14 Bn 197.54 Bn 7.24 Bn -
8 Gilead Sciences 194.83 Bn 169.02 Bn 6.22 Bn 9.00 Mn
9 Pfizer 172.37 Bn 119.01 Bn 10.94 Bn -
10 Polaryx Therapeutics 93.18 Mn 68.79 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 250,000.00
API Access

Polaryx Therapeutics Common Stock Issued API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-stock-issued&ticker=PLYX&period=max&api_key=YOUR_API_KEY